Prognostic Value of the Combination of Circulating Tumor Cells Plus KRAS in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab
Sastre, Javier, Vidaurreta, Marta, Gómez, Auxiliadora, Rivera, Fernando, Massutí, Bartomeu, López, Margarita Reboredo, Abad, Albert, Gallen, Manuel, Benavides, Manuel, Aranda, Enrique, Rubio, EduardoТом:
12
Мова:
english
Журнал:
Clinical Colorectal Cancer
DOI:
10.1016/j.clcc.2013.06.001
Date:
December, 2013
Файл:
PDF, 686 KB
english, 2013